US Patent 11040107 Dosing regimens and related compositions and methods
Patent 11040107 was granted and assigned to Apellis Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11040107 Dosing regimens and related compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.